±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 247  |  »Ø¸´: 2
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

ronghui05

Í­³æ (СÓÐÃûÆø)

[½»Á÷] ҽѧÀ࣬лл£¡

Gene therapy and viro therapy are among the approaches currently used to treat malignant tumors. Gene therapy and viro therapy use a specific therapeutic gene that causes death in cancer cells. In early attempts at gene therapy, therapeutic genes were driven by ubiquitous promoters such as the CMV promoter, which induce non-specific toxicity to normal cells and tissues in addition to the cancer cells. Recently, novel cancer- and/or tissue-specific promoter systems have been developed to target cancer cells but not normal cells including stem cells. In this review, we describe cancer and/or tissue-specific gene therapy systems for the treatment of cancer. In particular, we will discuss three systems for gene therapy and virotherapy: i) tissue-specific promoter systems, ii) cancer-specific promoter systems, and iii) oncolytic virotherapy. We will also discuss the major challenges of cancer-targeting vector systems and future directions in this area.

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Íô¶«Éýwds

гæ (СÓÐÃûÆø)

¡ï ¡ï ¡ï
ronghui05(½ð±Ò+3,VIP+0):лл£¡ 1-16 09:49
Gene therapy and viro therapy are among the approaches currently used to treat malignant tumors. Gene therapy and viro therapy use a specific therapeutic gene that causes death in cancer cells. In early attempts at gene therapy, therapeutic genes were driven by ubiquitous promoters such as the CMV promoter, which induce non-specific toxicity to normal cells and tissues in addition to the cancer cells. Recently, novel cancer- and/or tissue-specific promoter systems have been developed to target cancer cells but not normal cells including stem cells. In this review, we describe cancer and/or tissue-specific gene therapy systems for the treatment of cancer. In particular, we will discuss three systems for gene therapy and virotherapy: i) tissue-specific promoter systems, ii) cancer-specific promoter systems, and iii) oncolytic virotherapy. We will also discuss the major challenges of cancer-targeting vector systems and future directions in this area.
»ùÒòÖÎÁÆ»òÕß²¡¶¾ÖÎÁÆÊÇĿǰ¶Ô¸¶¶ñÐÔÖ×ÁöµÄ·½·¨¡£»ùÒòÖÎÁƺͲ¡¶¾ÖÎÁÆÊ¹ÓÃÒ»¸öÄÜÖÂËÀ°©Ï¸°ûµÄÌØÒìÐÔÖÎÁÆ»ùÒò¡£ÔÚÔçÆÚµÄ»ùÒòÖÎÁÆÊÔÑéÖУ¬ÖÎÁÆ»ùÒòÊÇÓÉÒ»¸öͨÓÃµÄÆô¶¯×ÓÇý¶¯µÄ£¬±ÈÈçCMVÆô¶¯×Ó£¬Ëü³ýÁË¿ÉɱËÀ°©Ï¸°ûÍ⣬»¹¿ÉÓÕµ¼²úÉúÕë¶ÔÕý³£Ï¸°ûºÍÆ÷¹ÙµÄ¶¾ÐÔ¡£×î½ü£¬Ðµİ©Ï¸°û»òÆ÷¹ÙÌØÒìÐÔÆô¶¯×ÓϵͳÒѾ­¿ª·¢³öÀ´£¬ÆäÖ±Ö¸°©Ï¸°û£¬È´²»Ó°ÏìÕý³£Ï¸°ûºÍ¸Éϸ°û¡£ÔÚÏÂÎÄÖУ¬ÎÒÃǽ«»áÊöÓÃÓÚ°©Ö¢ÖÎÁư©Ï¸°û»ò×éÖ¯ÌØÒìÐÔÆô¶¯×Óϵͳ¡£ÎÒÃÇ»áרÃÅÌÖÂÛÈý¸ö»ùÒò»ò²¡¶¾ÖÎÁÆÏµÍ³£º1¡¢Æ÷¹ÙÌØÒìÐÔÆô¶¯×Óϵͳ£»2¡¢°©Ï¸°ûÌØÒìÐÔÆô¶¯×Óϵͳ£»3¡¢ÈÜÁö²¡¶¾ÖÎÁÆ¡£ÎÒÃÇÒ²»áÌÖÂÛÄ¿µÄ°©Ï¸°ûÔØÌåϵͳµÄÖ÷ÒªÌôÕ½¼°ÕâÒ»ÁìÓòµÄδÀ´·½Ïò
2Â¥2010-01-15 16:21:47
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yjhorn

ľ³æ (ÕýʽдÊÖ)

¡ï ¡ï ¡ï
ronghui05(½ð±Ò+3,VIP+0):лл£¡ 1-16 09:49
Å×שÒýÓñ£º
»ùÒòÖÎÁƺͲ¡¶¾ÖÎÁÆÊÇĿǰÖÎÁƶñÐÔÖ×Áö·½·¨ÖÐµÄÆäÖÐÁ½ÖÖ¡£»ùÒòÖÎÁƺͲ¡¶¾ÖÎÁÆÊÇʹÓÃÒ»¸öÌØÒìÐÔÖÎÁÆÐÍ»ùÒòÀ´É±ËÀ°©Ï¸°û¡£ÔÚ»ùÒòÖÎÁÆÊ¹ÓõÄÔçÆÚ½×¶Î£¬Ò»Ð©ÖÎÁÆÐÍ»ùÒòÊÇÓÉÒ»¸öͨÓÃµÄÆô¶¯×ÓÇý¶¯µÄ£¬±ÈÈçCMVÆô¶¯×Ó£¬ÕâÑù¿ÉÓÕ·¢Õý³£Ï¸°ûºÍ×éÖ¯ÒÔ¼°°©Ï¸°ûµÄ·ÇÌØÒìÐÔ¶¾ÐÔ¡£½üÀ´£¬£¨¿ÆÑ§¼Ò£©ÒÑ¿ª·¢³öÁËÐµİ©Ï¸°û»ò×éÖ¯ÌØÒìÐÔÆô¶¯×Óϵͳ£¬Æä°Ð±êÊǰ©Ï¸°û£¬µ«²¢²»Ó°ÏìÕý³£Ï¸°ûºÍ¸Éϸ°û¡£±¾ÎÄÎÒÃǽ«½éÉÜÓÃÓÚÖÎÁư©Ö¢µÄ°©Ö¢»ò×éÖ¯ÌØÒìÐÔÆô¶¯×Óϵͳ£¬ÓÈÆäÊÇÏÂÁÐÈý¸ö»ùÒò»ò²¡¶¾ÖÎÁÆÏµÍ³£º1¡¢×éÖ¯ÌØÒìÐÔÆô¶¯×Óϵͳ£»2¡¢°©Ö¢ÌØÒìÐÔÆô¶¯×Óϵͳ£»3¡¢ÈÜÁö²¡¶¾ÖÎÁÆ¡££¨Í¬Ê±£¬£©ÎÒÃÇÒ²»áÌÖÂÛ°©Ö¢°ÐÏòÔØÌåϵͳ£¨ÃæÁٵģ©Ö÷ÒªÌôÕ½¼°¸ÃÁìÓòδÀ´µÄ£¨·¢Õ¹£©·½Ïò¡£
ÈÏʶ´ó¼ÒÊÇÔµ·Ö°¡£¡
3Â¥2010-01-15 20:10:32
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ronghui05 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 270»¯¹¤Çóµ÷¼Á +6 º£Ì¦»¨Éú±ý 2026-03-28 6/300 2026-04-04 09:05 by zhangdingwa
[¿¼ÑÐ] Çó²ÄÁϵ÷¼Á£¬Ò»Ö¾Ô¸Ö£ÖÝ´óѧ289·Ö +15 ˶ÐǸ° 2026-04-03 15/750 2026-04-04 01:01 by userper
[¿¼ÑÐ] 265Çóµ÷¼Á +20 ÁºÁºÐ£Ð£ 2026-04-01 21/1050 2026-04-04 00:38 by userper
[¿¼ÑÐ] 322Çóµ÷¼Á +6 FZAC123 2026-04-03 6/300 2026-04-03 22:23 by ¿ÆÑÐСר¼Ò
[¿¼ÑÐ] µ÷¼Á +8 JLLLLLLLLLL 2026-04-03 8/400 2026-04-03 22:06 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] Êý¶þÓ¢¶þ348Çóµ÷¼Á +4 hxdzj1 2026-04-03 5/250 2026-04-03 21:25 by zhq0425
[¿¼ÑÐ] 0835ѧ˶299Çóµ÷¼Á 08´óÀà¿É½ÓÊÜ +3 useryy 2026-04-03 3/150 2026-04-03 20:23 by zhq0425
[¿¼ÑÐ] 329Çóµ÷¼Á£¬Ò»Ö¾Ô¸Î÷±±¹¤Òµ´óѧ£¬²ÄÁϹ¤³Ì£¨085601£© +8 СС»úÁ鳿 2026-03-29 14/700 2026-04-03 19:38 by lijunpoly
[¿¼ÑÐ] 301Çóµ÷¼Á +14 A_JiXing 2026-04-01 14/700 2026-04-03 18:31 by lsÁõ˧
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤306·ÖÕÒµ÷¼Á +10 ²×º£ÇáÖÛe 2026-04-03 11/550 2026-04-03 11:07 by à£à£à£0119
[¿¼ÑÐ] 085600 295·ÖÇóµ÷¼Á +19 W55j 2026-03-30 23/1150 2026-04-03 09:53 by ǧǧÔËÆø
[¿¼ÑÐ] һ־Ըɽ¶«´óѧ»¯Ñ§Ó뻯¹¤Ñ§Ôº²ÄÁÏÓ뻯¹¤×¨Ë¶£¬360·ÖÇóµ÷¼Á +4 ²»Ô¸Í¸Â¶ÐÕÃûµÄË 2026-04-02 4/200 2026-04-03 09:29 by ÒÅÍüÏûʧµÄž™
[¿¼ÑÐ] 372·Ö²ÄÁÏÓ뻯¹¤£¨085600£©Ò»Ö¾Ô¸ºþÄÏ´óѧÇóµ÷¼Á +5 À¶¼ãƬ 2026-04-02 6/300 2026-04-02 21:37 by dongzh2009
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ085601²ÄÁϹ¤³ÌÓ¢Ò»Êý¶þ³õÊÔ×Ü·Ö335Çóµ÷¼Á +8 Ë«ÂíβƦÀϰå2 2026-04-02 9/450 2026-04-02 14:45 by 5896
[¿¼ÑÐ] 377Çóµ÷¼Á +3 RASKIN 2026-04-02 3/150 2026-04-02 09:45 by zzchen2000
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ085601²ÄÁϹ¤³ÌÓ¢Ò»Êý¶þ³õÊÔ×Ü·Ö335Çóµ÷¼Á +5 Ë«ÂíβƦÀϰå2 2026-03-31 5/250 2026-04-01 09:04 by oooqiao
[¿¼ÑÐ] Ò»Ö¾Ô¸´óÁ¬Àí¹¤´óѧ²ÄÁÏÇóµ÷¼Á +6 Gymno 2026-03-30 6/300 2026-03-31 07:26 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] µ÷¼Á +4 GK72 2026-03-30 4/200 2026-03-30 20:32 by dick_runner
[¿¼ÑÐ] Çóµ÷¼Á +7 Çà´º²ÃΪÈý½Ø 2026-03-29 7/350 2026-03-30 13:14 by laoshidan
[¿¼ÑÐ] 085602 »¯Ñ§¹¤³Ìר˶ 340·ÖÇóµ÷¼Á +4 qianbai11 2026-03-29 4/200 2026-03-30 11:34 by ÌÆãå¶ù
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û